SANTA CLARA, Calif. -- Agilent Technologies, Inc. (NYSE: A) today announced that NIMGenetics S.L. of Madrid has achieved Certified Service Provider (CSP) status for genomic research using Agilent SurePrint comparative genomic hybridization (CGH) and CGH/SNP microarrays.
'We are very proud to become the first Agilent CSP in Spain,' said Dr. Juan Cruz Cigudosa, NIMGenetics chief scientific officer. 'We offer personalized customer service for research professionals that helps them with the design and selection of the most appropriate platform, up to a complete bioinformatics analysis, working with arrayCGH, gene expression arrays and microRNA platforms. NIMGenetics provides services in Spain and worldwide, offering the best products to improve characterization reliability.'
'We're very pleased to welcome this esteemed organization to our growing team of CSPs,' said Robert Schueren, Agilent vice president and general manager, Genomics. 'NIMGenetics has a history of innovation and quality in investigating the effects of alterations in DNA copy numbers, and it's gratifying to see Agilent CGH tools performing a substantial role in this work.'
'We have been collaborating for years with NIMGenetics and their associated academic partners,' added Pascal Le Floch-Riché, Agilent Southern Europe genomics sales manager. 'Their advanced team specializes in the development of genetic research and, supported by our leading array technology, has been accredited by the Spanish Association of Human Genetics.'
NIMGenetics became the first Agilent CSP in Spain after completing training and passing a rigorous series of assessments that included demonstrating proficiency in the complete Agilent integrated microarray workflow: Agilent CGH and CGH/SNP microarrays, sample labeling, hybridization, scanning on the Agilent DNA microarray scanner with feature extraction software, data analysis using GeneSpring and/or Agilent Genomic Workbench software, and sample quality control on the Agilent 2100 Bioanalyzer.
Agilent offers the industry's only CGH and CGH/SNP microarrays in a wide range of formats, which customers can custom-design at no cost using Agilent's eArray online tool. Options range from a single array containing 1 million features through eight individual arrays on a standard 1-in. x 3-in. wafer. The company also manufactures genome-wide CGH arrays for human, mouse, rat and other model organisms.
For more information about Agilent CGH microarrays or Agilent's entire portfolio of genomics products, visit www.genomics.agilent.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications. The company's 18,500 employees serve customers in more than 100 countries. Agilent had net revenues of $5.4 billion in fiscal 2010. Information about Agilent is available at www.agilent.com.